bayer.com
May 16, 2008
Berlin, May 16, 2008 - Randomized Phase III trial of sorafenib versus placebo in Asian patients with advanced hepatocellular carcinoma o Ann Lii-Cheng, MD, PhD, department of internal medicine, National Taiwan University Hospital, Taipei, Taiwan o Abstract #4509, oral presentation, Monday, June...
[read full story]